Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Agilent Joins Picometrics in Biopharma Deal

Facebook Twitter LinkedIn Email
Agilent Technologies Inc. and Picometrics Technologies have signed a co-marketing agreement to improve efficiency in the research and development of complex large-molecule biopharmaceutical compounds.

Analysis technology tools such as capillary electrophoresis (CE), laser-induced fluorescence (LIF) detection and mass spectrometry are particularly useful for the research and development of new biological entities, said Michael Frank, marketing director of liquid phase separations at Agilent.

“As conventional drug research becomes outmoded in meeting the increasing demands of complex, large-molecule drug development, scientists need highly sophisticated tools like these to advance therapeutic discovery,” Frank said.

Several Agilent products can be used with Picometrics’ Zetalif LED and Zetalif Laser instruments, including Agilent’s CE and CE/mass spectrometry technologies, as well as HPLC/UHPLC (high-performance liquid chromatography / ultrahigh-pressure liquid chromatography) solutions.

For more information, visit: or

Apr 2014
The study and measurement of spectra and their components.
Agilent TechnologiesAmericasbiopharmaceuticalBiophotonicsBusinessCaliforniaCEEuropeFranceHigh-performance liquid chromatographyLiFMarketingMicroscopyRapidScanResearch & TechnologyspectrometryspectroscopyPicometrics Technologiescapillary electrophoresislaser-induced fluorescence detectionZetalif LEDZetalif laserCE/MSHPLC/UHPLCultrahigh-pressure liquid chromatographynew biological entitieslasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.